Recently, Bollywood renowned actor Irrfan Khan broke the news that he has been diagnosed with a neuroendocrine tumour and will be travelling to the UK for treatment.
This week, however, rumours that Irrfan is in the last stages of cancer took over social media once again. It was reported that the Hindi Medium star only has one month left to live. Fortunately, the rumours are false and Irrfan’s spokesperson has asked people to desist from spreading such stories, reported Hindustan Times.
The spokesperson said, “This latest round of news being spread through social media in the last few days about Irrfan’s health is absolutely false and there’s no truth to it whatsoever.”
He continued, “We, as his family and friends, again request the members of the media to continue their support and the prayers that have come Irrfan’s way. However, it’s not right to spread rumours through mediums of social media without fact check or any official validation. In the meanwhile, once again, we request everyone to refrain from picking up social media statuses as affirmative developments on someone’s health.”
According to his wife Sutapa Sikdar, Irrfan is facing the illness like a “warrior.” She took to Facebook to share her sentiments, thanked the well-wishers for their support and like Irrfan, urged people not to speculate about his condition.
“My best friend and my partner is a ‘warrior’. He is fighting every obstacle with tremendous grace and beauty. I want all of you to know I am truly humbled and indebted for the wishes, prayers and concern from all over the world,” Sutapa wrote.
Various media reports have been speculating over the medical condition that has struck Khan. Sutapa stated, “I know curiosity germinates from concern but let us turn our curiosity from ‘what it is’ to ‘what it should be.’ Let us change the leaf. Let us not waste our precious energies to only know what it is and just pray to make it what it should be.”
Stay tuned for more updates!
https://www.pakistanlounge.pk/irrfan-khan-suffering-neuroendocrine-tumour/
